enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. New prostate cancer medication 'shows promise' in treating ...

   www.aol.com/news/prostate-cancer-medication...

   The new drug "shows promise in treating advanced or aggressive prostate cancer," a doctor told Fox News Digital. "We know that CDK 9 is an enzyme associated with prostate cancer growth," he told ...

3. Management of prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Management_of_prostate_cancer

   Management of prostate cancer. Treatment for prostate cancer may involve active surveillance, surgery, radiation therapy – including brachytherapy (prostate brachytherapy) and external-beam radiation therapy, proton therapy, high-intensity focused ultrasound (HIFU), cryosurgery, hormonal therapy, chemotherapy, or some combination.

4. Breakthrough reverses prostate cancer’s resistance to treatment

   www.aol.com/breakthrough-reverses-prostate...

   Prostate Cancer UK’s director of research, Dr Matthew Hobbs, said he is “extremely excited” about the findings. ... “A man living with advanced prostate cancer needs treatments that will ...

5. Molecule ‘shows promise’ as effective first line of prostate ...

   www.aol.com/molecule-shows-promise-effective...

   Prostate cancer is the most common cancer in men in the UK, with more than 52,000 cases diagnosed every year on average. Current treatments include radiation, chemotherapy, hormone deprivation ...

6. Androgen deprivation therapy - Wikipedia

   en.wikipedia.org/wiki/Androgen_deprivation_therapy

   Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent ...

7. STAMPEDE (clinical trial) - Wikipedia

   en.wikipedia.org/wiki/STAMPEDE_(clinical_trial)

   STAMPEDE (clinical trial) Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) is a clinical trial investigating treatments for high risk or terminal prostate cancer. Recruitment started in 2005 and ended in 2022; as of January 2020, over 10,000 participants had joined the trial.